Latest News

A tense exchange on vaccines between Greens Senator Richard Di Natale and Department of Health Secretary Professor Brendan Murphy at this morning's hearing of the Senate inquiry into COVID-19.

Australian company QBiotics has announced a new agreement with MSD to progress the development of its lead molecule tigilanol tiglate in patients with unresectable melanoma.

There is no guarantee any COVID-19 vaccine will be approved but you would think the middle of a pandemic that has caused a global economic and health-system catastrophe is a time to show some urgency and take a few risks on health innovation.

Merck says it is celebrating National Science Week (15-23 August) by highlighting how funding from industry is supporting research and helping to build Australia’s world-class medical and science sector.

Medicines Australia will not rush to accept any extension to its existing 'strategic agreement' with the federal government.

Indonesia might now be the regional leader after licensing and committing to manufacturer Sinovac's vaccine that has just entered late-stage trials while the US has invested another US$1.5 billion for 100 million doses of Moderna's mRNA vaccine.

Dr Brendan Shaw says President Donald Trump’s new ‘Buy American’ executive order on essential medicines, medical countermeasures and critical inputs, has thrown a 'cat amongst the pigeons' and could have serious implications for Australia’s medicine and medical device exporters.

A license for AstraZeneca's COVID-19 vaccine could be one of the few choices left because of Australia's limited manufacturing capability and the UK company's agreement to conditions set by its partner Oxford University.

Indonesian president Joko Widodo announced that PT Bio Farma has committed to manufacturing Sinovac's late-stage vaccine, to the extent of supplying 250 million doses per year from December 2020.

One of the challenges countries and companies confront in negotiating 'advance purchase arrangements' for one of the investigative COVID-19 vaccines is how to manage the potential for future product liability claims.

The federal departments of health and industry have jointly issued a 'Request for Information' (RFI) on Australia's vaccine manufacturing capability - two months after industry minister Karen Andrews said they were already working on mapping the country's capability.

The federal government is in discussions with the companies about a deal under which AstraZeneca will license the investigative vaccine (AZD1222) it is developing with The University of Oxford to CSL